Prediction of Propofol Effect-Site Concentration Associated With Deep Anesthesia - Trial NCT06346158
Access comprehensive clinical trial information for NCT06346158 through Pure Global AI's free database. This phase not specified trial is sponsored by Ciusss de L'Est de l'Île de Montréal and is currently Not yet recruiting. The study focuses on Anesthesia. Target enrollment is 110 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ciusss de L'Est de l'Île de Montréal
Timeline & Enrollment
N/A
May 01, 2024
May 01, 2025
Primary Outcome
Concentration at the effect-site propofol associated with deep anesthesia (CeDA)
Summary
The goal of this observational study is to explore the variability of the concentration at
 the effect site (Ce) of propofol to reach deep anesthesia (DA) during induction of general
 anesthesia in adults.
 
 The investigators hypothesized that there is a great variability in this Ce that could be
 precisely explained by
 
 - Electroencephalographic (EEG) features available prior to induction of anesthesia
 
 - Cognitive performance
 
 - Patients characteristics Participants will undergo preoperative cognitive testing and
 awake EEG. Then, induction of general anesthesia will be performed using continuous
 infusion of propofol. The Ce at which Deep anesthesia is observed will be recorded.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06346158
Non-Device Trial